Every material Form 8-K Repligen filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Repligen reported third-quarter 2024 revenue of $155 million, up 10% from a year earlier, and narrowed its full-year 2024 revenue guidance to $630 million-$639 million while keeping the midpoint unchanged. GAAP results swung to a small loss, which the company attributed in part to $17.4 million of incremental stock compensation tied to the CEO's transition to Executive Chair, and the filing references a prior restatement of financial statements.
Q3 2024 revenue $155 million vs. $141 million in Q3 2023, up 10%
GAAP net loss of $0.7 million, or $0.01 per diluted share, vs. net income of $17 million, or $0.30 per share
Adjusted (non-GAAP) diluted EPS $0.43 vs. $0.23; includes $17.4 million of CEO transition stock compensation excluded from adjusted results
Repligen said its prior financial statements should no longer be relied upon and will be restated for 2023 and the first half of 2024, after a $17.3 million COVID-related customer cancellation payment was recognized in the wrong period. The company identified a material weakness in internal control over financial reporting, and its internal review is ongoing. Management reaffirmed 2024 revenue guidance of $627 million to $642 million, saying overall revenue and cash are unchanged.
A $17.3 million payment received in April 2023 should have been deferred and recognized as products were delivered, with all open orders delivered by June 30, 2024.
Restated full-year 2023 total revenue is $632.2 million versus $638.8 million as reported; restated 2023 GAAP income from operations is $48.0 million versus $54.6 million as reported.
Restated first-half 2024 total revenue is $312.0 million versus $305.4 million as reported; restated first-half 2024 GAAP income from operations is $10.1 million versus $3.5 million as reported.
The company identified a material weakness in internal controls over revenue recognition and said it may identify further changes to previously reported amounts.
Repligen reported second quarter 2024 revenue of $154 million, down from $159 million a year earlier, and adjusted earnings per share of $0.33, down from $0.53. GAAP earnings per share fell to $0.06 from $0.35, and the company narrowed its full-year revenue guidance while leaving adjusted EPS guidance unchanged.
Q2 2024 revenue was $154 million versus $159 million in Q2 2023; first half revenue was $305 million
Q2 GAAP income from operations was $1 million versus $19 million; GAAP diluted EPS was $0.06 versus $0.35
Full-year 2024 revenue guidance narrowed to $620 million-$635 million; adjusted EPS guidance unchanged at $1.42-$1.49
Q2 results include $4.4 million of incremental stock compensation tied to the CEO transition to Executive Chair
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Repligen filing is on SEC EDGAR ↗. 8-K briefs of other companies →